Trellus Health plc TRLHF

Company Overview

Trellus Health plc is a digital health company focused on improving outcomes for people living with chronic gastrointestinal (GI) conditions, with an initial and primary emphasis on inflammatory bowel disease (IBD). The company operates at the intersection of healthcare technology, behavioral science, and specialty care, providing evidence-based digital therapeutics and integrated care solutions designed to complement traditional medical treatment. Trellus Health primarily serves healthcare providers, health systems, employers, and life sciences partners seeking scalable solutions to manage chronic GI conditions and associated healthcare costs.

The company’s core offering is a proprietary digital care platform that combines cognitive behavioral therapy (CBT), self-management education, and remote care coordination. Trellus Health positions itself uniquely by targeting the psychosocial drivers of chronic disease outcomes, which are often under-addressed in conventional care models. The company was founded in 2016 by Dr. Laurie Keefer, a behavioral health expert in gastroenterology, and evolved from an academic research-based model into a commercial digital health enterprise. Trellus Health became a publicly traded company in 2022 following a business combination with a special purpose acquisition company, resulting in its listing on U.S. public markets.